Genezen is a cell and gene therapy biotechnology company that provides viral vector production to clients at every stage in the industry. The company offers various viral vector platforms with multiple production processes from the preclinical phase into clinical production. They can also assist with the development and scale-up production of a client’s ex vivo gene transfer and cell therapy clinical trials. Genezen’s state-of-the-art, 60,000-sq.-ft. cGMP facility outside of Indianapolis offers a full suite of CDMO services to their clients.










